An Act to promote transparency and cost control of pharmaceutical drug prices

Filed by Mark C. Montigny · 16 cosponsors · 189th General Court · the legislature's own page

S1048 · Bill · docket SD1726

9 actions

In the order the legislature recorded them.

Date	Branch	Action
2015-04-15	Senate	Referred to the committee on Mental Health and Substance Abuse
2015-04-15	House	House concurred
2015-09-10	Senate	Discharged to the committee on Health Care Financing
2015-09-14	House	House concurred
2016-02-12	Joint	Hearing scheduled for 03/22/2016 from 11:00 AM-04:00 PM in Gardner Auditorium
2016-03-16	Joint	Hearing canceled – new hearing TBD
2016-04-29	Senate	Reporting date extended to Wednesday June 1, 2016, pending concurrence
2016-05-02	House	Adopted, in concurrence
2016-06-02	Senate	Accompanied a study order, see S2307

1 of these was struck from the record by the clerk and shown ruled through, because a struck line is part of what the record says happened.

House Rule 27 counts its reporting deadline from the day a bill is heard.

Date	Committee	Where	Status
2016-04-11	Health Care Financing (J)	B-1, 24 Beacon Street, Boston	Completed

Action	Committee
Discharge to Another Committee	Mental Health and Substance Abuse (J)
Accompanied	Health Care Financing (J)

In the order filed.

Every action here is as the legislature published it. A bill that drew no recorded vote is the ordinary case: the House records roughly 150 a year.